AI assistant
HOLOGIC INC — Director's Dealing 2018
Nov 14, 2018
30407_dirs_2018-11-14_fcec1822-22c5-4e3a-82ba-024da6f8c479.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HOLOGIC INC (HOLX)
CIK: 0000859737
Period of Report: 2018-11-12
Reporting Person: Valenti Peter J. III (Division Pres., Breast Health)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-12 | Common Stock | A | 8542 | — | Acquired | 65422 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-12 | Non-qualified Stock Option (Right to Buy) | $40.97 | A | 26080 | Acquired | 2028-11-12 | Common Stock (26080) | Direct |
Footnotes
F1: Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 12, 2018.
F2: Restricted stock units are settled in shares of common stock on a one-for-one basis.
F3: Includes 20,644 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
F4: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 12, 2018.